000 | 01986 a2200505 4500 | ||
---|---|---|---|
005 | 20250514200332.0 | ||
264 | 0 | _c20041217 | |
008 | 200412s 0 0 eng d | ||
022 | _a1470-1626 | ||
024 | 7 |
_a10.1530/rep.1.00234 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aQiu, Q | |
245 | 0 | 0 |
_aEGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways. _h[electronic resource] |
260 |
_bReproduction (Cambridge, England) _cSep 2004 |
||
300 |
_a355-63 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aBlotting, Western _xmethods |
650 | 0 | 4 |
_aButadienes _xpharmacology |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aChromones _xpharmacology |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aEpidermal Growth Factor _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xanalysis |
650 | 0 | 4 |
_aMitogen-Activated Protein Kinase Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aMorpholines _xpharmacology |
650 | 0 | 4 |
_aNitriles _xpharmacology |
650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aProto-Oncogene Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aProto-Oncogene Proteins c-akt |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-1 _xanalysis |
650 | 0 | 4 |
_aTrophoblasts _xmetabolism |
700 | 1 | _aYang, M | |
700 | 1 | _aTsang, B K | |
700 | 1 | _aGruslin, A | |
773 | 0 |
_tReproduction (Cambridge, England) _gvol. 128 _gno. 3 _gp. 355-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1530/rep.1.00234 _zAvailable from publisher's website |
999 |
_c15031251 _d15031251 |